Last weeks JAMA had two articles on GLP-1 drugs that point to their promise for treatment of diseases beyond the conditions for which they are already approved by the FDA: obesity, diabetes, cardiovascular risk, sleep apnea and metabolic liver disease
[Evaluation of efficacy of propionyl-L-carnitine in chronic oral administration on cardiac muscle efficiency, on tolerance to exercise and on life quality of patients with chronic cardiac failure
They cite a lack of research
Its more of a gradual process, and understanding the typical timeline can really help manage your expectations
Without resistance training, creatine provides some cellular-level benefits (cell volumization, hydration), but the majority of its muscle-preserving effects depend on being combined with exercise that challenges your muscles
Liposomal formulations improve absorption by encasing the glutathione molecule in a lipid layer that protects it during digestion